October 9, 2015
Recommended Topic Related To:


"By Kelli Miller
WebMD Health News
Reviewed by Brunilda Nazario, MD

March 5, 2015 -- Babies created from the DNA of two women and a man could be born as early as next year. Last month, the United Kingdom cleared the way for fert"...


Discontinued Warning IconPlease Note: This Brand Name drug is no longer available in the US.
(Generic versions may still be available.)



Aside from possible ovarian hyperstimulation and multiple gestations (see WARNINGS), little is known concerning the consequences of acute overdosage with FertinexTM (urofollitropin for injection, purified).


FertinexTM (urofollitropin for injection, purified) is contraindicated in women who exhibit :

1. High levels of FSH indicating primary ovarian failure.

2. Uncontrolled thyroid or adrenal dysfunction.

3. An organic intracranial lesion such as a pituitary tumor.

4. The presence of any cause of infertility other than anovulation, as stated in the "Indications" unless they are candidates for Assisted Reproductive Technologies.

5. Abnormal bleeding of undetermined origin (see INDICATIONS: Selection of Patients).

6. Ovarian cysts or enlargement of undetermined origin.

7. Prior hypersensitivity to urofollitropin.

Fertinex (urofollitropin) TM is also contraindicated in women who are pregnant and may cause fetal harm when administered to a pregnant woman. There are limited human data on the effects of Fertinex (urofollitropin) TM when administered during pregnancy.

Last reviewed on RxList: 12/8/2004
This monograph has been modified to include the generic and brand name in many instances.


Report Problems to the Food and Drug Administration


You are encouraged to report negative side effects of prescription drugs to the FDA. Visit the FDA MedWatch website or call 1-800-FDA-1088.

Trying to Conceive

Get tips and advances in treatment.